200 related articles for article (PubMed ID: 25775155)
1. The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.
Rayner B; Ramesar R
Int J Mol Sci; 2015 Mar; 16(3):5741-9. PubMed ID: 25775155
[TBL] [Abstract][Full Text] [Related]
2. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
Bhatnagar V; O'Connor DT; Brophy VH; Schork NJ; Richard E; Salem RM; Nievergelt CM; Bakris GL; Middleton JP; Norris KC; Wright J; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS;
Am J Hypertens; 2009 Mar; 22(3):332-8. PubMed ID: 19119263
[TBL] [Abstract][Full Text] [Related]
3. GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.
Zhang Y; Wang S; Huang H; Zeng A; Han Y; Zeng C; Zheng S; Ren H; Wang Y; Huang Y; Jose PA; Ma XL; Zeng C; Chen K
Clin Sci (Lond); 2020 Sep; 134(18):2453-2467. PubMed ID: 32940654
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.
Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Watanabe T; Moore JH; Ritchie MD; Williams SM; Pezzullo JC; Sasaki M; Eisner GM; Jose PA; Felder RA
Clin Chem; 2006 Mar; 52(3):352-60. PubMed ID: 16439609
[TBL] [Abstract][Full Text] [Related]
5. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.
Felder RA; Jose PA
Nat Clin Pract Nephrol; 2006 Nov; 2(11):637-50. PubMed ID: 17066056
[TBL] [Abstract][Full Text] [Related]
7. Role of GRK4 in the regulation of the renal ETB receptor in hypertension.
Yang Y; Li M; Zou X; Chen C; Zheng S; Fu C; Chen K; Jose PA; Lan C; Liu Y
FASEB J; 2020 Sep; 34(9):11594-11604. PubMed ID: 32687659
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression.
Sanada H; Yatabe J; Midorikawa S; Katoh T; Hashimoto S; Watanabe T; Xu J; Luo Y; Wang X; Zeng C; Armando I; Felder RA; Jose PA
Hypertension; 2006 Jun; 47(6):1131-9. PubMed ID: 16636192
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Exposure of Fine Particulate Matter Causes Hypertension by Impaired Renal D
Lu X; Ye Z; Zheng S; Ren H; Zeng J; Wang X; Jose PA; Chen K; Zeng C
J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29307864
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Renal G Protein-Coupled Receptor Kinase Type 4 Expression via Ultrasound-Targeted Microbubble Destruction Lowers Blood Pressure in Spontaneously Hypertensive Rats.
Huang H; Li X; Zheng S; Chen Y; Chen C; Wang J; Tong H; Zhou L; Yang J; Zeng C
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792639
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.
Jose PA; Soares-da-Silva P; Eisner GM; Felder RA
Biochim Biophys Acta; 2010 Dec; 1802(12):1259-67. PubMed ID: 20153824
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.
Yang J; Hall JE; Jose PA; Chen K; Zeng C
Pharmacol Ther; 2022 Nov; 239():108194. PubMed ID: 35487286
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.
Cao N; Tang H; Tian M; Gong X; Xu Z; Zhou B; Lan C; Chen C; Qu S; Zheng S; Ren H; Fan C; Jose PA; Zeng C; Xia T
Clin Exp Hypertens; 2021 Oct; 43(7):597-603. PubMed ID: 33899625
[No Abstract] [Full Text] [Related]
14. Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.
Yatabe J; Sanada H; Midorikawa S; Hashimoto S; Watanabe T; Andrews PM; Armando I; Wang X; Felder RA; Jose PA
Hypertens Res; 2008 Jul; 31(7):1455-64. PubMed ID: 18957817
[TBL] [Abstract][Full Text] [Related]
15. G-protein-coupled receptor kinase 4 causes renal angiotensin II type 2 receptor dysfunction by increasing its phosphorylation.
Zhang F; Lei L; Huang J; Wang W; Su Q; Yan H; Chen C; Zheng S; Ren H; Li Z; Jose PA; Hu Y; Si L; Zeng C; Yang J
Clin Sci (Lond); 2022 Jun; 136(12):989-1003. PubMed ID: 35695067
[TBL] [Abstract][Full Text] [Related]
16. Gender-based differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years.
Lee M; Kim MK; Kim SM; Park H; Park CG; Park HK
PLoS One; 2015; 10(3):e0120111. PubMed ID: 25768006
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4.
Staessen JA; Kuznetsova T; Zhang H; Maillard M; Bochud M; Hasenkamp S; Westerkamp J; Richart T; Thijs L; Li X; Brand-Herrmann SM; Burnier M; Brand E
Hypertension; 2008 Jun; 51(6):1643-50. PubMed ID: 18413491
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and the kidney: a role in hypertension?
Jose PA; Eisner GM; Felder RA
Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):189-94. PubMed ID: 12589180
[TBL] [Abstract][Full Text] [Related]
19. The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.
Armando I; Konkalmatt P; Felder RA; Jose PA
Transl Res; 2015 Apr; 165(4):505-11. PubMed ID: 25134060
[TBL] [Abstract][Full Text] [Related]
20. Dopamine Receptor D
Zeng C; Armando I; Yang J; Jose PA
Yale J Biol Med; 2023 Mar; 96(1):95-105. PubMed ID: 37009199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
